Novel receptor nucleic acids and polypeptides
AssigneeBiogen Idec MA Inc.
InventorsChristine M. Ambrose, Jeffrey S. Thompson
Life of this patent
Estimating the term…
Abstract
Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceutical compositions of this invention are also provided.
Claims55
An isolated nucleic acid comprising a sequence encoding a polypeptide at least 50% identical to a polypeptide comprising the amino acid sequence of SEQ ID NO:5.
An isolated nucleic acid comprising a nucleotide sequence complementary to at least a portion of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:6.
A method of diagnosing a B-cell mediated condition in a subject, the method comprising:
- providing a protein sample from said subject;
- measuring the amount of BAFF-R polypeptide in said subject sample;
- and
- comparing the amount of BAFF-R polypeptide in said subject protein sample to the amount of BAFF-R polypeptide in a control protein sample, wherein an alteration in the amount of BAFF-R polypeptide in said subject protein sample relative to the amount of BAFF-R polypeptide in said control protein sample indicates the subject has a B-cell mediated condition.
A method of diagnosing a B-cell mediated condition in a subject, the method comprising:
- providing a nucleic acid sample from said subject;
- measuring the amount of BAFF-R nucleic acid in said subject nucleic acid sample;
- and
- comparing the amount of BAFF-R nucleic acid sample in said subject nucleic acid to the amount of BAFF-R nucleic acid in a control sample, wherein an alteration in the amount of BAFF-R nucleic acid in said sample relative to the amount of BAFF-R in said control sample indicates the subject has a B-cell mediated condition.
A method of diagnosing a B-cell mediated condition in a subject, the method comprising:
- providing a nucleic acid sample from said subject;
- identifying at least a portion of the nucleotide sequence of a BAFF-R nucleic acid in said subject nucleic acid sample;
- and
- comparing the BAFF-R nucleotide sequence of said subject sample to a BAFF-R nucleotide sequence of a control sample, wherein an alteration in the BAFF-R nucleotide sequence in said sample relative to the BAFF-R nucleotide sequence in said control sample indicates the subject has a B-cell mediated condition.
A method for identifying a compound that binds BAFF-R protein comprising:
- a) contacting BAFF-R protein with a compound;
- and
- b) determining whether said compound binds BAFF-R protein.
A method for identifying a compound that binds a nucleic acid encoding BAFF-R protein comprising the steps of:
- a) contacting said nucleic acid encoding BAFF-R protein with a compound;
- and
- b) determining whether said compound binds said nucleic acid molecule.
A method for identifying a compound that modulates the activity of BAFF-R protein comprising the steps of:
- a) contacting BAFF-R protein with a compound;
- of
- b) determining whether BAFF-R protein activity has been modulated.
A method of decreasing aggregation of a recombinantly expressed protein comprising
- a) identifying regions of conserved amino acids between homologs of a target protein that aggregates as a recombinantly expressed protein;
- b) substituting at least one non-conserved amino acid in said target protein to form a mutated target protein;
- wherein said mutated target protein displays reduced aggregation when recombinantly expressed.
An isolated nucleic acid molecule encoding at least a portion of a BAFF-R protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:13;
- SEQ ID NO:15;
- SEQ ID NO:16;
- SEQ ID NO:17;
- SEQ ID NO:18;
- SEQ ID NO:19;
- SEQ ID NO:20;
- SEQ ID NO:21;
- SEQ ID NO:22;
- SEQ ID NO:23;
- SEQ ID NO:24;
- SEQ ID NO:25;
- SEQ ID NO:26;
- SEQ ID NO:27;
- SEQ ID NO:28;
- SEQ ID NO:29;
- SEQ ID NO:30;
- SEQ ID NO:31;
- and SEQ ED NO:32.
An isolated nucleic acid molecule encoding a BAFF-R protein comprising an amino acid sequence of SEQ ID NO:14.
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:13;
- SEQ ID NO:15;
- SEQ ID NO:16;
- SEQ ID NO:17;
- SEQ ID NO:18;
- SEQ ID NO:19;
- SEQ ID NO:20;
- SEQ ID NO:21;
- SEQ ID NO:22;
- SEQ ID NO:23;
- SEQ ID NO:24;
- SEQ ID NO:25;
- SEQ ID NO:26;
- SEQ ID NO:27;
- SEQ ID NO:28;
- SEQ ID NO:29;
- SEQ ID NO:30;
- SEQ ID NO:31;
- and SEQ ID NO:32.
An isolated murine BAFF-R polypeptide comprising an amino acid sequence of SEQ ID NO:14.
Dependencies are inferred from the claim text.